From: Oral midazolam vs. intranasal dexmedetomidine plus oral midazolam for sedation of pediatric outpatients: a double-blinded randomized controlled trial
Variables
M group
DM group
P
delirium
2(4.7%)
0
0.495
diplopia
1(2.3%)
1.00
nausea and vomiting
agitation
1 (2.5)
loss of coordination
1(2.5%)
0.482
bradycardia
lethargy
5(12.5%)*
0.023